Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Anti-Cancer Agents in Medicinal Chemistry|October 26, 2019
Zoning in on Tankyrases: A Brief Review on the Past, Present and Prospective StudiesXylia Q Peters, Thembeka H Malinga, Clement Agoni, et al.
Biomolecules|April 30, 2025
Molecular Modelling in Bioactive Peptide Discovery and CharacterisationClement Agoni, Raúl Fernández-Díaz, Patrick Brendan Timmons, et al.
Journal of Molecular Modeling|January 10, 2021
A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenaseKehinde F Omolabi, Emmanuel A Iwuchukwu, Clement Agoni, et al.
Cell Biochemistry and Biophysics|June 28, 2020
'Polymorphism-aided' Selective Targeting and Inhibition of Caspase-6 by a Novel Allosteric Inhibitor Towards Efficient Alzheimer's Disease TreatmentRansford Oduro Kumi, Clement Agoni, Abdul Rashid Issahaku, et al.
Combinatorial Chemistry & High Throughput Screening|February 14, 2022
Extended Double Bond Conjugation in the Chalcone Framework Favours MAO-B Inhibition: A Structural Perspective on Molecular DynamicsClement Agoni, Abdul Rashid Issahaku, Mohamed A Abdelgawad, et al.
Chemistry & Biodiversity|October 25, 2023
Computational Screening of Neuropilin-1 Unveils Novel Potential Anti-SARS-CoV-2 TherapeuticsMichael Afiadenyo, Latif Adams, Clement Agoni, et al.
Journal of Lipids|January 13, 2017
Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema MetropolisRichard K D Ephraim, Patrick Adu, Edem Ake, et al.
Bioinformatics (Oxford, England)|September 18, 2024
AutoPeptideML: a study on how to build more trustworthy peptide bioactivity predictorsRaúl Fernández-Díaz, Rodrigo Cossio-Pérez, Clement Agoni, et al.
Scientific Reports|October 23, 2022
Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapyAbdul Rashid Issahaku, Namutula Mukelabai, Clement Agoni, et al.
Cell Biochemistry and Biophysics|January 18, 2022
Prioritizing the Catalytic Gatekeepers through Pan- Inhibitory Mechanism of Entrectinib against ALK, ROS1 and TRKA Tyrosine KinasesElliasu Y Salifu, Abdul Rashid Issahaku, Clement Agoni, et al.
Pageof 7